Xiaoting Huang

ORCID: 0000-0001-6970-993X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer Risks and Factors
  • Acute Lymphoblastic Leukemia research
  • Prostate Cancer Treatment and Research
  • Neurological Disorders and Treatments
  • Glioma Diagnosis and Treatment
  • Neurological Disease Mechanisms and Treatments
  • Global Cancer Incidence and Screening
  • Balance, Gait, and Falls Prevention
  • HER2/EGFR in Cancer Research
  • Gastric Cancer Management and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Vestibular and auditory disorders
  • Cancer Immunotherapy and Biomarkers
  • Brain Metastases and Treatment
  • Advanced Breast Cancer Therapies
  • Acupuncture Treatment Research Studies
  • Colorectal Cancer Screening and Detection
  • Multiple and Secondary Primary Cancers
  • Nutritional Studies and Diet
  • PARP inhibition in cancer therapy
  • Tourism, Volunteerism, and Development
  • Job Satisfaction and Organizational Behavior
  • Inflammatory Bowel Disease

Fujian Medical University
2020-2025

First Affiliated Hospital of Fujian Medical University
2020-2025

Changi General Hospital
2025

Guangxi Medical University
2025

Singapore General Hospital
2024

Shandong University
2020-2023

Shenzhen University
2023

Shandong Management University
2022-2023

Central University of Finance and Economics
2023

Guangzhou Medical University
2022

Green technological innovation is one of the endogenous drivers green economic growth, and digitalization can promote development in form industrial empowerment. The interactive relationship degree influence between digitalization, innovation, thus an urgent issue to be addressed. Based on panel data 30 Chinese provinces from 2011 2019, we measured for first time using entropy method included them same analytical framework by constructing a PVAR model empirically test their interrelationship...

10.3390/ijerph191912273 article EN International Journal of Environmental Research and Public Health 2022-09-27

We present a novel deep network (namely BUSSeg) equipped with both within- and cross-image long-range dependency modeling for automated lesions segmentation from breast ultrasound images, which is quite daunting task due to (1) the large variation of lesions, (2) ambiguous lesion boundaries, (3) existence speckle noise artifacts in images. Our work motivated by fact that most existing methods only focus on within-image dependencies while neglecting dependencies, are essential this under...

10.1109/tmi.2022.3233648 article EN IEEE Transactions on Medical Imaging 2023-01-02

Objective: The authors conducted a cost-effectiveness analysis incorporating recent phase III clinical trial (IMpassion130) data to evaluate the of atezolizumab in combination with nab-paclitaxel (AnP) against alone as first-line treatment for advanced triple-negative breast cancer developed and developing countries. Materials Methods: A decision-analytic Markov model was using IMpassion130 AnP over lifetime from US health care payer Chinese system perspective. Model inputs were derived...

10.1097/coc.0000000000000671 article EN American Journal of Clinical Oncology 2020-02-05

Abstract Background Benign Paroxysmal Positional Vertigo (BPPV) is the commonest cause of vertigo in older adults. Due to its high incidence adults presenting with falls, vestibular assessment recommended World Guidelines for Falls Prevention. There a paucity evidence well conducted randomised controlled trials (RCTs) evaluate vitamin D prevention BPPV recurrence relation falls and function. Aims Primary outcome: does supplementation dietary interventions combination standard care impact...

10.1007/s40520-025-02938-4 article EN cc-by Aging Clinical and Experimental Research 2025-02-22

Objective: To investigate the levels of insulin-like growth factor-1 (IGF-1) and receptor (IGF-1R) in serum placenta patients with preeclampsia (PE), establish their correlations, evaluate diagnostic potential. Methods: 22 PE normal pregnant women who underwent cesarean section deliveries at First Affiliated Hospital Guangxi Medical University between December 2021 2022 were included observation group control group. Enzyme-linked immunosorbent assay (ELISA) was utilized to measure IGF-1...

10.2147/ijwh.s512910 article EN cc-by-nc International Journal of Women s Health 2025-03-01

<title>Abstract</title> <bold>Purpose</bold> To comprehensively compare the risk of cardiotoxicity with 5-HT3RAs and to explore underlying pharmacokinetic factors that might partially contribute cardiotoxicity. <bold>Methods</bold> The FDA Adverse Event Reporting System (FAERS) data (January 2004 March 2023) were extracted. Disproportionality analysis by calculating relative odds ratio (ROR) sensitivity analyses conducted assess cardiac signals 5-HT3RAs. Additionally, various parameter...

10.21203/rs.3.rs-6213342/v1 preprint EN Research Square (Research Square) 2025-04-03

Abstract Objective To determine if the recurrence rates of BPPV in older adults were lower vitamin D‐treated group as compared to placebo groups. Study Design Double‐blinded randomized control trial. Setting A single‐centre study. Methods controlled trial design with 12 months follow‐up. Vitamin D3 deplete participants into treatment (Group A) or groups B). Treatment received 13 weeks 2000 IU followed by 1000 for next weeks. Patients who replete allocated a C) observation and follow up. All...

10.1002/ohn.954 article EN cc-by-nc-nd Otolaryngology 2024-08-28

Acupuncture has many advantages in the treatment of certain diseases as opposed to drug therapy. Besides, adenosine been revealed affect cellular progression including proliferation. Therefore, this study aimed at exploring mechanism involving acupuncture stress and fibroblast The fibroblasts from fascia tissues acupoint area (Zusanli) were stimulated by different levels stress, concentrations adenosine, agonist or antagonist A3 receptor (A3 R) investigate effect stimulation, adenosine-A3 R...

10.1002/jcp.29148 article EN Journal of Cellular Physiology 2019-09-25

Combination therapy of zoledronic acid (ZOL) plus aromatase inhibitor (AI) was found to reduce bone metastasis risk and improve overall survival for treatment-naïve postmenopausal women (PMW) with hormone receptor-positive (HR+) early breast cancer (EBC), when compared AI alone. The objective this study evaluate the cost-effectiveness adding ZOL in treating PMW HR+ EBC China. A 5-state Markov model constructed PMW-EBC over a lifetime horizon from perspective Chinese healthcare provider. Data...

10.1093/intqhc/mzad016 article EN other-oa International Journal for Quality in Health Care 2023-03-27

10.1016/j.annals.2023.103664 article EN Annals of Tourism Research 2023-10-21

This study aimed to analyze the cost-effectiveness of combining screening for thiopurine methyl transferase (TPMT) and nucleotide triphosphate diphosphatase (NUDT15) defective alleles with therapeutic drug monitoring (TDM) in Chinese patients inflammatory bowel disease (IBD) treated azathioprine (AZA).We evaluated NUDT15 TPMT deficiency TDM receiving AZA treatment over a 1-year horizon by developing decision tree model. Real-world data published literature were used derive model inputs. The...

10.21037/atm-21-1980 article EN Annals of Translational Medicine 2021-07-01

Abstract Purpose To investigate the cost‐effectiveness of lenvatinib plus pembrolizumab (LP) compared to chemotherapy as a second‐line treatment for advanced endometrial cancer (EC) from United States and Chinese payers' perspective. Methods In this economic evaluation, partitioned survival model was constructed perspective payers. The data were derived clinical trial (309‐KEYNOTE‐775), while costs utility values sourced databases published literature. Total costs, quality‐adjusted life...

10.1111/jog.15910 article EN Journal of Obstetrics and Gynaecology Research 2024-03-14

Aim: To compare the cost–effectiveness of olaparib versus control treatment in metastatic castration-resistant prostate cancer patients with at least one gene mutation BRCA1, BRCA2 or ATM from US payer perspective. Methods: A Markov model was constructed to assess quality-adjusted life years (QALYs) and incremental ratios. Sensitivity analyses scenario were conducted explore impact uncertainties. Results: The base-case result indicated that, for specific mutations, gained 1.26 QALYs...

10.2217/pgs-2021-0061 article EN Pharmacogenomics 2021-08-01

Background: Life expectancy for patients with malignant tumors has been significantly improved since the presence of programmed cell death protein-1/programmed protein ligand-1 (PD-1/PD-L1) inhibitors in 2014, but they impose heavy financial burdens patients, healthcare system and nations. The objective this study was to determine survival benefits, toxicities, monetary quantify their values. Methods: Randomized controlled trials (RCTs) PD-1/PD-L1 were identified clinical benefits quantified...

10.3389/fphar.2023.1114304 article EN cc-by Frontiers in Pharmacology 2023-02-23

Abstract STUDY QUESTION Is it economically worthwhile to use GnRH agonist (GnRHa) prevent menopausal symptoms (MS) and protect fertility in premenopausal women with breast cancer (BC) during chemotherapy from the US perspective? SUMMARY ANSWER It is cost-effective administer GnRHa order forefend MS patients BC when willingness-to-pay (WTP) threshold $50 000.00 per quality-adjusted life-year (QALY), preserve young who undergo oocyte cryopreservation (OC), or no OC, WTP thresholds live birth...

10.1093/humrep/dead073 article EN Human Reproduction 2023-04-19

Objective The S0226 trial demonstrated that the combination of half-dose fulvestrant (FUL) and anastrozole (ANA) (F&amp;A) caused a significant improvement in overall survival (OS) versus ANA monotherapy for first-line treatment postmenopausal women with hormone receptor-positive metastatic breast cancer (PMW-MBC (HR+)). objective this study was to evaluate cost-effectiveness F&amp;A PMW-MBC (HR+) China. Design We constructed Markov model over life-time horizon. clinical outcomes utility...

10.1136/bmjopen-2019-036107 article EN cc-by-nc BMJ Open 2020-08-01

The aim of this study was to evaluate the disease burden prostate cancer (PC) and assess key influencing factors associated with expenditures PC in United States.The total deaths, incidence, prevalence, disability-adjusted life-years were obtained from Global Burden Disease Study 2019. Medical Expenditure Panel Survey used estimate healthcare productivity loss investigate patterns payment use resources States. A multivariable logistic regression model conducted identify expenditures.For...

10.4178/epih.e2023038 article EN cc-by Epidemiology and Health 2023-03-21
Coming Soon ...